Strategies in Pharma
November 14, 2023 | Terry Sharrer
MAIN rarely includes pieces about the business of big pharma, but this item may be interesting to all of us, as it raises a conundrum about personalized medicine—how tailoring drugs to personalized targets drives costs beyond reason.
Image Credit: FierceBiotech.com